Ipamorelin has similar properties to GHRP-6 because they release growth hormone in the same strength.As it is the most stable form of ghrelin with a long half-life and a secondary role in stimulating neurons.Ipamorelin increases the level of acetylcholine in the system, which means that neural communication is optimal, which blocks cellular receptors and responds to growth hormone.According to research, hormone increases gastric motility,and its mechanism of action is through the activation of specific G protein secretagogues.Scientist found Ipamorelin is highly effective and very selective both in vivo and in vitro, and also exhibits good safety and tolerability in human clinical studies.Studies have shown that Ipamorelin is growth hormone-specific, which means that pituitary hormones such as cortisol are not affected. In one study, bone mass was observed in young female adult rats due to treatment with ipamorelin for 12 weeks.
After 12 weeks of treatment with ipamorelin, scientise observed there is bone mass in young female adult rats.
In addition,this peptide ensures benefits compared to other somatotropin-releasing peptides without the need to deal with possible negative side effects.